Abstract
Various “cell therapy” approaches have been proposed to overcome extreme loss of insulin-producing pancreatic β cells in patients with type 1 diabetes. Transplantation of donor islets of Langerhans is being investigated actively, but the number of patients with type 1 diabetes far outstrips the current donor supply. Embryonic …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
